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Operative salvage of radiocephalic arteriovenous
fistulas by formation of a proximal neoanastomosis
Mekhola Mallik, MBBS, MRCS, Rajesh Sivaprakasam, MBChB, MRCS, Gavin J. Pettigrew, MD, FRCS,
and Chris J. Callaghan, PhD, FRCS, Cambridge, United Kingdom
Objective: We examined the outcomes of radiocephalic arteriovenous fistulas salvaged by formation of a neoanastomosis
in the proximal cephalic vein segment.
Methods: Patients with a radiocephalic arteriovenous fistula revised by formation of a neoanastomosis in the proximal
cephalic vein segment were identified from a prospectively maintained database and outcomes retrospectively analyzed.
Results: Eighty patients had 81 radiocephalic arteriovenous fistulas revised by formation of a neoanastomosis in the
proximal cephalic vein segment. Failure to mature was the indication for revision in 39 (48.1%), 17 (21.0%) were revised
for poor flows during dialysis, and 25 (30.9%) were performed for thrombosis. Primary patency of the 81 neoanastomoses
at 12, 24, and 36 months was 78.5%, 68.9%, and 54.9%, respectively. Compared with neoanastomoses that were
performed on 50 immature radiocephalic arteriovenous fistulas, those performed on the 31 mature fistulas exhibited
improved patency rates (P  .04). There was no difference in the primary patency of the neoanastomosis between those
performed for 25 failed fistulas and 56 failing (but patent) fistulas (P .15). There was one case (1.2%) each of bleeding,
infection, and steal after neoanastomosis. Four patients (4.9%) required further interventions on their neoanastomoses.
Conclusions: Operative salvage of radiocephalic arteriovenous fistulas by formation of a neoanastomosis in the proximal
cephalic vein segment demonstrates good patency and low complication rates and can be performed with reasonably good
results in patients with failed or failing (but patent) radiocephalic arteriovenous fistulas. These patients should not
automatically proceed to elbow fistula formation; rather, proximal neoanastomosis should be considered. (J Vasc Surg
2011;54:168-73.)
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aThe radiocephalic arteriovenous wrist fistula (RCAVF)
is the gold standard venous access for patients who require
long-term hemodialysis.1 Compared with prosthetic grafts,
autogenous fistulas demonstrate superior patency rates,
lower infection rates, and fewer postoperative complica-
tions.2 Placement of the RCAVF at the wrist reduces the
risk of steal syndrome compared with elbow fistulas3 and
preserves more proximal vessels for future access place-
ment. However, RCAVFs have been reported to have a
high primary failure rate because of early thrombosis or
failure to mature to permit adequate dialysis,4,5 and there-
fore, a proportion require reintervention by operative or
endovascular means to achieve long-term patency.6-8 Pres-
ent evidence favors operative salvage of autogenous
AVFs,7,9-11 although randomized controlled trials are lack-
ing. It is similarly possible to surgically salvage RCAVFs
that havematured and are either failing (but patent) or have
failed. By avoiding creation of a new fistula at the elbow,
this avoids consumption of precious venous capital.
Previous studies analyzing outcomes after operative
salvage of RCAVFs have described a variety of techniques,
including most commonly, creation of a new anastomosis
From the University Department of Surgery, Addenbrooke’s Hospital.
Competition of interest: none.
Correspondence: Dr M. Mallik, University Department of Surgery, Box
202, Addenbrooke’s Hospital, Hills Rd, Cambridge, CB2 0QQ, UK
(e-mail: mm852@cam.ac.uk).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00t
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.12.050
168t a proximal site on the radial artery using patent forearm
ephalic vein. This operation has been named the NEO
rocedure.12 Less commonly described alternatives include
enous patching or placement of an interposition vein graft.
here outcomes for a single operative technique have been
escribed, case numbers have generally been small.9,12-15
Larger, more detailed, analyses of outcomes after spe-
ific techniques enable more meaningful comparisons be-
ween surgical procedures and between surgical and endo-
ascular therapies. The aims of this study were therefore to
xamine the outcomes and complications of operative sal-
age of RCAVFs by the NEO technique.
ETHODS
Data collection. Patients undergoing operative sal-
age of an RCAVF from October 1, 2001, to October 31,
009, were identified from a prospectively maintained da-
abase. Case notes were examined for operative details.
nly patients undergoing operative salvage by NEO were
ncluded; RCAVFs revised by any other surgical technique
ere excluded. Patients were followed up until December
1, 2009.
Initial RCAVF creation. Patients underwent preop-
rative clinical assessment with ultrasound imaging only
hen the clinical examination was equivocal, because we
ave previously demonstrated that clinical examination
lone can suffice, in most cases.16 Because of concerns
egarding long-term patency2 and infection,17 our policy is
ot to use prosthetic grafts, and instead, RCAVFs are the
referred initial dialysis access. Because we do not stipulate
minimum venous diameter that precludes fistula forma-
ion, these are performed in approximately 80% of pa-
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Volume 54, Number 1 Mallik et al 169tients.16 A standard end-to-side anastomosis between the
cephalic vein and radial artery was performed by senior
surgical trainees and consultants with a specialist interest in
vascular access surgery. During the study period, 624 pri-
mary RCAVFs were created.
Reassessment of problematic RCAVFs. Indications
for referral for reassessment of RCAVFs were guided by the
National Kidney Foundation Kidney Disease Outcomes
Quality Initiative guidelines11 and included inadequate
dialysis provision, recirculation 5%, reduction in pump
speed 100 mL/min from baseline in three consecutive
dialysis sessions, suspected thrombosis, cannulation diffi-
culty, and failure to mature (defined as vein size of6 mm
diameter 8 weeks after formation). All patients requiring
reassessment underwent clinical examination and ultra-
sound imaging. Contrast fistulography was performed ac-
cording to the assessing surgeon’s preference.
Operative technique. Our unit policy is to salvage fis-
tulas operatively rather than by endovascular intervention. No
patient underwent endovascular intervention on an RCAVF
or a revised RCAVF during the study and follow-up periods.
All fistulas were scannedwith a SonoSiteMicroMaxx portable
ultrasound unit (SonoSite Inc, Herts, UK) before surgery to
locate venous stenoses or the proximal extent of thrombus, or
both. Distal thrombectomy was not performed; neoanasto-
mosis was performed only at sites of patent vein because we
believe that thrombectomized endothelium is prone to re-
thrombosis. Where thrombus extended proximally to involve
the proximal half of the forearm cephalic vein, salvage was not
performed and a new fistula was created at an alternative site.
Similarly, NEO was not performed when the clinical or ultra-
sound examination showed the radial artery was heavily dis-
eased or when scarring of the cephalic vein was noted at the
first operation.
NEO procedures were performed under local anes-
thetic as out-patient procedures, where possible, although
patients with acute thromboses of functioning RCAVFs
often required admission for venous catheter placement
and emergency dialysis. A curvilinear incision in the distal
third of the forearm was made over the cephalic vein and
radial artery, and the original access was ligated and over-
sewn at the distal extent of disease-free vein. The proximal
cephalic vein was mobilized, and an end-to-side anastomo-
sis to the radial artery was performed using 6-0 or 7-0
nonabsorbable monofilament continuous suture.
Definitions and statistical analysis. A fistula was con-
sidered mature if it had provided successful dialysis for at least
three consecutive sessions andobviated theneed for dialysis by
central catheter or peritoneal dialysis. Similarly, immature
fistulas were those that had never provided adequate func-
tional dialysis and therefore included those fistulas that re-
mained predialysis throughout the study period. Primary pa-
tency was defined as the interval from the time of initial
RCAVF placement until any intervention designed to main-
tain or re-establish patency, as noted by Sidawy et al.18 Pri-
mary patency of theNEOwas defined as the interval from the
time of NEO formation until any intervention designed to
maintain or re-establish patency. Survival curves were gener- rted by Kaplan-Meier analysis. Patients were censored in the
vent of transplant, death, or final measurement of patency.
urvival was compared using the log-rank test. Statistical anal-
ses were performed using SPSS 17.0 software (SPSS Inc,
hicago, Ill).
ESULTS
The NEO technique was used in 80 patients for 81
evisions of RCAVFs (1 patient had bilateral NEOs). Just
even NEOs were performed between the start of the study
eriod and October 1, 2005. Patients were monitored after
urgery for a median of 2.5 years (range, 2.5 months-8.2
ears), and in this interval, 16 patients (20.0%) died and 15
18.8%) received transplants. During the study period, a fur-
her 14 RCAVFs underwent surgical salvage using alternative
echniques, including resection of venous stenosis with veno-
enous anastomosis in 7, ligation of venous collaterals in 3,
ein patch to venous stenosis in 2, and revision using a
roximal tributary in 2. These are not included in the study.
Demographics and perioperative factors. The 80
atients undergoing NEO were a median age of 66 years old
range, 27-87 years), and there were 49men (61.3%). Patient
omorbidities were diabetes in 24 (30.0%), cardiovascular
isease in 39 (48.8%), smoking history in 35 (43.8%), while
4 (80.0%) were prescribed at least one antihypertensive
gent, and 63 (78.8%) were prescribed at least one antithrom-
otic agent. Of the 81 RCAVFs revised by NEO, 31 (38.3%)
ere on mature fistulas and 50 (61.7%) were on immature
stulas. Of the 31 NEOs performed on mature fistulas, 14
45.2%) were revised for thrombosis, and 17 (54.8%) were
evised for poor flow or high recirculation. Of the 50 NEOs
erformed on immature fistulas, 11 (22.0%) were revised for
hrombosis, and 39 (78.0%) were revised for failure tomature
n the absence of thrombosis. Senior surgical trainees per-
ormed 56 of the 81 NEOs (69.1%) and 64 (79.0%) were
erformed under local anesthetic alone. The NEOs were
erformed as out-patient procedures in 49 (60.5%), 31
38.3%) were performed on an in-patient basis, and the hos-
ital length of stay in 1 patient (1.2%) was not known. The
ommonest reason for admission was emergency dialysis (8 of
1; 25.8%).
Complications and further procedures. Eight (9.9%)
erioperative complications were documented, including 4
EOs failed on-table, 1 patient had excessive bleeding
equiring intravenous fluid and overnight admission, 1
atient experienced epistaxis while on a heparin infusion, 1
atient was readmitted 2 weeks postoperatively with a
ound infection that led eventually to rupture of the fistula
nd ligation, and 1 patient was readmitted 2 weeks for
teal syndrome requiring NEO ligation. Four (4.9%) pa-
ients required revision surgery on their NEOs: three had
edo NEOs on an existing NEO (the time interval between
he first and second NEO ranged from 9.6 to 41.1
onths), and one had superficialization of the NEO.
Patency. Primary patency of the initial RCAVF was
7.0% at 12 months (Fig 1). A poor primary patency rate
as expected, because by definition, this population all
equired reintervention. Typical patency rates for fistula
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acceptable long-term primary patency rates of the NEO
were achieved (Fig 1). Thus, NEO formation extended the
life of an RCAVF; secondary patency at 48 months was
58.0% (Fig 1).
We hypothesized that mature fistulas would have better
patency rates after NEO than immature fistulas due to
larger arterial and venous diameters. Patency rates for the
31 mature fistulas revised by NEO were superior to those
performed on the 50 immature fistulas; this difference was
statistically significant (P  .04; Fig 2, A). Of the 50
immature fistulas that were revised by NEO, successful
dialysis was achieved in 28 (56.0%), 14 (28.0%) never
achieved successful dialysis, and 8 (16.0%) were performed
in patients who remained predialysis throughout the study
period.
We then examined the effect of RCAVF patency at the
Fig 1. Patency rates of radiocephalic arteriovenous fistu
were poor (37.0%, 17.3%, and 6.2% at 12, 24 and 36 m
neoanastomoses (NEO) were acceptable (78.5%, 68.9%
squares). Consequently, the overall (secondary) patency fo
(87.3%, 81.2%, and 72.0% at 12, 24, and 36 months, resp
(SE) exceeds 10%, the survival curve has been depicted w
Patency  SE, % (N) 12 mo
Primary patency of RCAVF 37.0  5
Primary patency of NEO 78.5  5
Secondary patency (RCAVF  NEO) 87.3  3time of NEO formation on subsequent primary patency of mhe NEO. We divided our population undergoing NEO
nto the 25 patients who had a revision for a failed (throm-
osed) fistula and 56 who had a revision for a failing (but
atent) fistula (ie, those with poor flows, high recirculation,
r failure to mature). Although there was some separation
f the survival curves early on (Fig 2, B), overall there was
o statistically significant difference in the patency of the
EO between the two groups (P  .15).
ISCUSSION
Here we report the outcome of a large cohort of
atients, all of whom underwent surgical salvage of their
CAVFs by proximal neoanastomosis using patent fore-
rm cephalic vein. Our study differs from existing litera-
ure in that previous publications have not generally
istinguished between the different types of surgical
evision performed or whether the original RCAVF had
CAVFs). Whereas primary patency rates of the RCAVF
s, respectively; solid line), primary patency rates of the
54.9% at 12, 24, and 36 months, respectively; open
RCAVFs was substantially improved byNEO formation
ely; crosses [n 81]; P .01). Where the standard error
dotted line. N, Number of fistulas at risk.
24 months 36 months
0) 17.3  4.2 (14) 6.2  2.7 (5)
0) 68.9  6.4 (20) 54.9  9.0 (5)
3) 81.2  4.6 (43) 72.0  6.0 (24)las (R
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who underwent NEO, results were reported only as a
combined outcome for a larger group of 157 patients
who underwent RCAVF salvage surgery that was per-
formed using various techniques. A comparably large
study by Ponikvar et al20 examined operative salvage, by
surgical thrombectomy or thrombectomy plus NEO, of
286 wrist and elbow arteriovenous fistulas and grafts,
but, similarly, only reported outcomes as a single group.
Where results have been reported on surgical techniques
separately, numbers have been small.7,9,12,13,15
Our results indicate that satisfactory salvage rates can
be achieved by performing NEO on failing (but patent),
Fig 2. Primary patency of the neoanastomoses (NEO) st
of the NEO performed on mature fistulas at 12, 24, and 3
n 31), whereas primary patency of the NEO of immatu
at 12, 24, and 36 months, respectively (squares, n  50
survival curve has been depicted with a dotted line. N, nu
Fistula 12 months
Mature 88.3  6.4 (20)
Immature 72.4  7.0 (20)or failed, RCAVFs. That this is the case for fistulas that dad matured and been previously used successfully for
ialysis is perhaps unsurprising. We did not perform
hrombectomy as part of the NEO procedure; the anas-
omosis was performed only at disease-free and patent
ites in the cephalic vein. By implication, these were
roximal to the stenotic lesions, which occur typically in
he juxta-anastomotic venous segment,11 and are re-
ponsible for flow limitation or thrombosis. The use of
n already arterialized and enlarged vein, anastomosed to
n artery that may also have undergone compensatory
nlargement, would be anticipated to achieve acceptable
ong-term patency. This formation of wider anastomoses
etween larger vessels may be the reason why steal
d by maturity and by patency status.A, Primary patency
nths was 88.3%, 78.6%, and 78.6%, respectively (circles,
ulas was significantly poorer at 72.4%, 62.5%, and 41.0%
.04). Where the standard error (SE) exceeds 10%, the
r of fistulas at risk.
atency  SE, % (N)
24 months 36 months
78.6  8.6 (10) 78.6  8.6 (3)
62.5  8.9 (10) 41.0  11.8 (3)ratifie
6 mo
re fist
; P 
mbe
Peveloped immediately after NEO formation in one
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with his original RCAVF.
The use of patent, disease-free vein may also explain why
patency rates of NEOs performed on RCAVFs that had
thrombosed were similar to those performed on patent fistu-
las. This differs from a study by Lipari et al,15 who reported
that revision of thrombosed fistulas carried an eightfold rela-
tive risk of access loss compared with revision of patent AVFs,
but notably in the Lipari study, thrombectomywas performed
and a variety of salvage techniques, including graft interposi-
tion and NEO formation, were used.
Somewhat more surprisingly, acceptable patency rates
were achieved by performing NEO on RCAVFs that had
not been successfully needled because of early thrombosis
Fig 2. B, Primary patency of the NEO for failed fistul
respectively (rectangles, n 25) and was comparable to fa
at 12, 24, and 36months, respectively (ovals, n 56; P
curve has been depicted with a dotted line. N, Number o
Fistula 12 months
Failed 68.8  10.0 (12)
Failing 83.3  5.4 (28)or failure to develop. The success of the NEO in this situation possibly reflects partial maturation of the cephalic
ein but also that the cause of failure of the original RCAVF
ay not relate to inherent problems with the “quality” of
he cephalic vein or radial artery. Certainly, a small number
f patients in our practice present with thrombosis of their
ascent fistula after documented hypotensive episodes.
Our secondary patency rate of 87.3% at 1 year com-
ares favorably with those reported at 1 year in studies
nvestigating endovascular interventions of failed or fail-
ng (but patent) fistulas: Turmel-Rodrigues et al21 re-
orted a secondary patency rate of 79%, Tessitore et al12
eported a secondary patency rate of 90%, and Beath-
rd et al22 reported a functional secondary patency rate
f 68%. In addition, studies have shown that although
12, 24, and 36 months was 68.8%, 56.0%, and 46.7%,
but patent) fistulas, which was 83.3%, 74.9%, and 59.0%
Where the standard error (SE) exceeds 10%, the survival
las at risk.
tency  SE, % (N)
24 months 36 months
6.0  11.6 (6) 46.7  12.9 (2)
4.9  7.5 (14) 59.0  11.7 (4)as at
iling (
.15).
f fistu
Pa
5
7urgical and endovascular interventions both demon-
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ventions are required to maintain patency by surgical
salvage.12 This may be because surgery avoids the risk of
luminal damage associated with endovascular interven-
tion.
On the basis of our findings, we advocate that rather
than automatically proceeding to elbow fistula formation,
patients with failed or failing (but patent) RCAVFs first
should be assessed for NEO salvage. However, our study
addresses neither the relative merits of NEO over other
salvage procedures nor the indications to perform salvage vs
creation of a new fistula at a different site.
One of the main weaknesses of our study is that stringent
criteria were not used to inform choice of intervention per-
formed. Rather, the decision to proceed to NEO was subjec-
tive, based principally on the assessing surgeon’s clinical ex-
amination and aided by ultrasound imaging. The NEO
techniquewas used for 81 of 95 (85.3%) of salvage procedures
performed for failing (but patent) or failed RCAVFs, but
notably during the study period, almost double the number of
patients (n 153) underwent new fistula creation at a differ-
ent site after failure of their RCAVF. Thus, the satisfactory
patency rates obtained for NEO may reflect careful selection
of patients where the likelihood of success was high. In this
regard, we are careful to perform a thorough clinical and
ultrasound examination so that the quality of the proximal
radial artery and cephalic vein are accurately assessed.
Although there is no clear consensus from the literature
about the optimal salvage option for revising RCAVFs, we
have generally viewed the NEO procedure as the treatment
of choice. Nevertheless, it is notable that the number of
NEO operations performed each year increased markedly
during the study period, suggesting that NEO salvage was
increasingly favored as experience accrued.
CONCLUSIONS
Our study demonstrates that surgical revision by NEO is
an effective, safe, and relatively straightforward procedure
that, in the absence of randomized controlled trials comparing
alternative revision techniques, may be considered a suitable
option for patients with failed or failing (but patent) RCAVFs.
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